GENOME ANNOUNCEMENT
===================

Clinical outcomes induced by *Helicobacter pylori* vary with individuals ([@B1]), especially among those with different ethnic origins ([@B2]). In fact, this is a hallmark of the Gram-negative curved bacterium that resides in the human stomach. Hypothetically, this variation could be due to the diversity of pathogenic genes present in the *H. pylori* strains infecting different ethnic groups ([@B1]), the geographically distinct DNA polymorphisms of *H. pylori* ([@B2], [@B3]), or the lifestyles of people of different ethnic groups ([@B4]). This phenomenon is not exceptional in multiracial Malaysia ([@B5]). Together with 10 previously announced genome sequences ([@B6]), which have been reassembled using newer algorithms, we present here 21 genome sequences of *H. pylori* strains isolated from patients with different ethnicities, disease statuses, and antimicrobial susceptibility patterns who were attending the endoscopy unit at the University of Malaya Medical Center (UMMC) ([Table 1](#tab1){ref-type="table"}).

###### 

Sequencing statistics, genome information, strain characteristics, and accession numbers for 21 *H. pylori* strains^[*c*](#ngtab1.1)^

  Strain^[*c*](#ngtab1.3)^   No. of contigs (≥200 bp)   ABySS *k*-mer   No. of scaffolds   No. of bases   Maximum scaffold size (bp)   Mean scaffold size (bp)   Median scaffold size (bp)   *N*~50~ (bp)   *N*~90~ (bp)   GC content (%)   No. of predicted genes (≥50 amino acids)   No. of annotated genes (E value \<10^--10^, PID ≥80%)   Remarks                            Accession no.
  -------------------------- -------------------------- --------------- ------------------ -------------- ---------------------------- ------------------------- --------------------------- -------------- -------------- ---------------- ------------------------------------------ ------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  FD662                      67                         47              24                 1,660,698      406,404                      69,196                    35,327                      212,690        31,444         38.92            1,623                                      1,556                                                   Malay; NUD                         [AKHT00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHT00000000)^[*a*](#ngtab1.1)^
  FD703                      89                         51              27                 1,678,101      311,702                      62,152                    22,813                      162,651        40,720         39.01            1,603                                      1,543                                                   Malay; NUD                         [AKHS00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHS00000000)^[*a*](#ngtab1.1)^
  FD719                      79                         53              24                 1,643,472      313,579                      68,478                    51,079                      97,163         37,907         39.07            1,609                                      1,543                                                   Malay; NUD                         [AKHU00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHU00000000)^[*a*](#ngtab1.1)^
  UM084                      34                         73              21                 1,657,009      332,847                      78,905                    51,819                      261,002        39,185         39.05            1,576                                      1,516                                                   Malay; PUD; MZ                     [AUSO00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSO00000000)^[*a*](#ngtab1.1)^
  FD423                      115                        51              26                 1,625,381      316,018                      62,515                    45,159                      97,115         37,787         39.09            1,599                                      1,538                                                   Indian; NUD                        [AKHM00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHM00000000)^[*a*](#ngtab1.1)^
  FD430                      130                        57              30                 1,643,626      212,462                      54,788                    41,777                      111,117        36,409         39.03            1,626                                      1,567                                                   Indian; NUD                        [AKHN00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHN00000000)^[*a*](#ngtab1.1)^
  FD535                      81                         51              24                 1,673,398      399,528                      69,725                    39,365                      117,068        38,267         39.04            1,608                                      1,554                                                   Indian; NUD                        [AKHP00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHP00000000)^[*a*](#ngtab1.1)^
  UM067                      44                         63              23                 1,681,714      564,610                      73,118                    35,626                      102,467        33,274         39.02            1,610                                      1,547                                                   Indian; PUD; MZ                    [AUSN00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSN00000000)^[*a*](#ngtab1.1)^
  UM114                      36                         49              24                 1,709,511      345,511                      71,230                    36,863                      259,963        31,894         38.91            1,623                                      1,559                                                   Indian; PUD; MZ                    [AUSS00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSS00000000)^[*a*](#ngtab1.1)^
  UM037                      60                         67              39                 1,724,611      234,132                      44,221                    29,236                      80,609         26,936         38.89            1,645                                      1,574                                                   Indian; stomach fundus tumor; CH   [AUSI00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSI00000000),^[*a*](#ngtab1.1)^ [CP005492](http://www.ncbi.nlm.nih.gov/nuccore?term=CP005492)^[*b*](#ngtab1.2)^
  FD506                      105                        51              26                 1,618,298      339,042                      62,242                    33,881                      135,883        33,881         38.66            1,578                                      1,533                                                   Chinese; NUD                       [AKHO00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHO00000000)^[*a*](#ngtab1.1)^
  FD568                      114                        59              24                 1,613,149      385,714                      67,215                    31,934                      169,920        38,934         38.64            1,566                                      1,528                                                   Chinese; NUD                       [AKHQ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHQ00000000)^[*a*](#ngtab1.1)^
  FD577                      74                         57              26                 1,627,035      362,981                      62,578                    41,783                      125,077        38,935         38.64            1,590                                      1,554                                                   Chinese; NUD                       [AKHR00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHR00000000)^[a](#ngtab1.1)^
  UM065                      39                         63              24                 1,587,249      334,064                      66,135                    40,061                      163,534        32,497         38.90            1,500                                      1,461                                                   Chinese; PUD                       [AUSM00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSM00000000)^[*a*](#ngtab1.1)^
  UM066                      34                         65              24                 1,694,309      319,894                      70,596                    39,327                      146,858        35,777         38.64            1,590                                      1,562                                                   Chinese; PUD                       [AUSJ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSJ00000000),^[*a*](#ngtab1.1)^ [CP005493](http://www.ncbi.nlm.nih.gov/nuccore?term=CP005493)^[*b*](#ngtab1.2)^
  GC26                       111                        55              27                 1,626,266      328,361                      60,232                    31,457                      152,049        31,457         38.64            1,592                                      1,561                                                   Chinese; GC                        [AKHV00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AKHV00000000)^[*a*](#ngtab1.1)^
  UM023                      35                         63              15                 1,624,154      485,260                      108,277                   53,518                      183,178        39,954         38.74            1,562                                      1,518                                                   Chinese; PUD; MZ                   [AUSK00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSK00000000)^[*a*](#ngtab1.1)^
  UM077                      53                         65              28                 1,620,877      328,671                      57,888                    35,423                      187,040        35,423         38.78            1,565                                      1,527                                                   Chinese; PUD; FQ                   [AUSQ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSQ00000000)^[*a*](#ngtab1.1)^
  UM038                      45                         63              27                 1,762,854      411,489                      65,291                    38,877                      94,812         35,087         38.42            1,663                                      1,602                                                   Chinese; NUD; CH, FQ               [AUSL00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSL00000000)^[*a*](#ngtab1.1)^
  UM085                      50                         75              29                 1,645,640      341,517                      56,746                    39,737                      94,888         39,574         38.72            1,568                                      1,524                                                   Chinese; NUD; CH, FQ               [AUSP00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSP00000000)^[*a*](#ngtab1.1)^
  UM111                      38                         59              29                 1,663,383      245,602                      57,358                    32,048                      110,134        30,450         38.68            1,581                                      1,536                                                   Chinese; NUD; CH, MZ               [AUSR00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AUSR00000000)^[*a*](#ngtab1.1)^

Illumina HiSeq 2000 (draft whole-genome sequence).

PacBio SMRT (complete genome sequence).

PID, percent identity; CH, clarithromycin resistant; FQ, fluoroquinolone resistant; GC, gastric cancer; MZ, metronidazole resistant; NUD, nonulcer dyspepsia; PUD, peptic ulcer disease.

*H. pylori* DNA was isolated using the RTP bacteria DNA minikit (Invitek GmbH, Berlin, Germany). Whole-genome sequencing was performed using 100-base, paired-end reads on the Illumina HiSeq 2000 instrument (Illumina, Inc., San Diego, CA) at the Malaysian Genomics Resource Centre Berhad (MGRC) (Kuala Lumpur, Malaysia). Assemblies were performed for each sample at optimal *k*-mers using the ABySS assembler version 1.3.4 ([@B7]). Assembled contigs were scaffolded with SSPACE using paired-end read information from each sample ([@B8]). Gene sequences were predicted from assembled scaffolds using GeneMark version 2.5 ([@B9]). Predicted gene sequences were aligned against the UniProt (Swiss-Prot/TrEMBL) database using SynaSearch (MGRC) for annotation.

Two strains, UM037 and UM066, were also sequenced using Pacific Biosciences RS sequencing technology (Pacific Biosciences, Menlo Park, CA), yielding \>20× average genome coverage. Each sample was prepared as a 10-kb insert library using C2 chemistry and sequenced on 8 single-molecule real-time (SMRT) cells. *De novo* assembly of the read sequences was carried out using continuous long reads (CLR) following the Hierarchical Genome Assembly Process (HGAP) workflow (PacBio DevNet; Pacific Biosciences) as available in SMRT Analysis v2.0. The genomes were annotated with the NCBI (National Center for Biotechnology Information) Prokaryotic Genomes Automatic Annotation Pipeline. Using the PacBio workflow, the *H. pylori* UM037 and UM066 genome sequences were assembled as single contigs of 1,692,823 bp and 1,660,425 bp, respectively. The NCBI annotation predicted 1,677 and 1,637 open reading frames (ORFs) (1,637 and 1,595 annotated genes) for UM037 and UM066, respectively.

The availability of these *H. pylori* genome sequences from individuals from different ethnic backgrounds with distinct clinical presentations provides the research community with a resource for detailed investigations into the genetic elements that correlate with bacterial evolution, compensatory mechanisms, host adaptation, gastric pathogenesis, and selective pressure exerted by antimicrobial agents. Furthermore, these sequencing data sets also enable the comparison of Illumina HiSeq and PacBio RS sequencing platforms for *H. pylori* genomes.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The *H. pylori* genome sequences described in this paper have been deposited as draft whole-genome shotgun projects in DDBJ/EMBL/GenBank under the accession numbers stated in [Table 1](#tab1){ref-type="table"}. The versions described in this paper are the first versions.
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